Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-31

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original ANDA for irbesartan and hydrochlorothiazide combination tablets from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)